Balyasny Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,177	Closed	-$26K	–	2888
2022 Q3	$26K	Buy	+11,177	New	+$26K	﹤0.01%	2064
2018 Q3	–	Sell	-28,920	Closed	-$222K	–	1860
2018 Q2	$222K	Buy	+28,920	New	+$222K	﹤0.01%	1436